Kura Oncology's total assets for Q2 2026 were $587.79M, a decrease of -9.92% from the previous quarter. DE:KUR total liabilities were $539.36M for the fiscal quarter, a -0.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.